Gulak, Jeany .
HRN: 22-43-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
CO-AMOXICLAV 625MG (TAB)
05/04/2023
05/11/2023
PO
625mg
BID
2 RMLE
Waiting Final Action